Equity
Other Equity
Eli Lilly Other Equity decreased by 13.6% to $19.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Significant changes may indicate share buyback programs or unique accounting adjustments that warrant further investigation in the footnotes.
Detailed definition
A catch-all category for equity components that do not fit into standard classifications like retained earnings or commo...
Peer comparison
Varies by company; often contains treasury stock which is common for companies with active share repurchase programs.
Metric ID:
other_equityHistorical Data
3 periods
| Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $31.00M | $22.00M | $19.00M |
| QoQ Change | — | -29.0% | -13.6% |
| YoY Change | — | -29.0% | — |
Range$19.00M – $31.00M
Avg YoY Growth-29.0%
Median YoY Growth-29.0%
Current Streak2+ quarters decline
Other Equity at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other equity?
- Eli Lilly (LLY) reported other equity of $19.00M in Q1 2026.
- What does other equity mean?
- Miscellaneous equity items not classified in major equity categories.